Literature DB >> 25429831

Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.

Vijaya Raj Bhatt1, Rishi Batra, Peter T Silberstein, Fausto R Loberiza, Apar Kishor Ganti.   

Abstract

Although a well-established risk factor for lung cancer, the impact of smoking on the survival of non-small cell lung cancer (NSCLC) is not well known. We performed a retrospective analysis of the Veteran's Affairs Comprehensive Cancer Registry of NSCLC patients. Smoking status was categorized as never smoker, past smoker and current smoker based on self-reported history. Multivariate analysis was performed to evaluate the impact of smoking on overall survival (OS) from NSCLC. The study population (n = 61,440) comprised predominantly of males (98 %) and Caucasians (81 %). The median age at diagnosis was 68 years (range 22-108 years). Current smokers were diagnosed with NSCLC at a younger age (65 years) compared to never smokers (71 years) and past smokers (72 years) (p < 0.001). On multivariate analysis, current smokers (n = 34,613) [Hazard ratio (HR) 1.059; 95 % confidence interval (CI) 1.012-1.108], but not past smokers (n = 23,864) (HR 1.008; 95 % CI 0.962-1.056), had worse OS for Stage III and IV NSCLC, compared to never smokers (n = 2,963). Smoking status was not prognostic in stages I and II NSCLC. Current smokers were diagnosed with NSCLC at a younger age than never smokers. Although current smoking was associated with worse prognosis, especially in stages III and IV, the impact of smoking status on OS was modest.

Entities:  

Mesh:

Year:  2014        PMID: 25429831     DOI: 10.1007/s12032-014-0339-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  48 in total

1.  Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.

Authors:  Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley
Journal:  Mil Med       Date:  2012-06       Impact factor: 1.437

2.  Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer.

Authors:  Charles R Mulligan; Amir D Meram; Courtney D Proctor; Hongyu Wu; Kangmin Zhu; Aizen J Marrogi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

3.  Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients.

Authors:  Michael Poullis; James McShane; Mathew Shaw; Michael Shackcloth; Richard Page; Neeraj Mediratta; John Gosney
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-16       Impact factor: 4.191

4.  Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women.

Authors:  J O Ebbert; B A Williams; Z Sun; M C Aubry; J A Wampfler; Y I Garces; R L Meyer; P Yang
Journal:  Lung Cancer       Date:  2005-02       Impact factor: 5.705

5.  Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.

Authors:  Sevin Baser; Vickie R Shannon; Georgie A Eapen; Carlos A Jimenez; Amir Onn; E Lin; Rodolfo C Morice
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

6.  Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.

Authors:  Ayesha Bryant; Robert James Cerfolio
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

7.  Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?

Authors:  Li-Han Hsu; Nei-Min Chu; Chia-Chuan Liu; Stella Y C Tsai; Dong-Ling You; Jen-Sheng Ko; Mei-Chun Lu; An-Chen Feng
Journal:  Lung Cancer       Date:  2009-03-18       Impact factor: 5.705

8.  Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.

Authors:  Sai-Hong Ignatius Ou; Argyrios Ziogas; Jason A Zell
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

9.  Gender differences in susceptibility to smoking among patients with lung cancer.

Authors:  Jeong-Seon Ryu; Sang-Hoon Jeon; Jung-Soo Kim; Jung Hwan Lee; Seong Hyun Kim; Ji Taek Hong; Ju Hong Jeong; Ji Joong Jeong; Myung Dong Lee; Sang Joon Min; Hae-Seong Nam; Jae-Hwa Cho; Seung-Min Kwak; Hong Lyeol Lee; Hyun-Jung Kim
Journal:  Korean J Intern Med       Date:  2011-11-28       Impact factor: 2.884

Review 10.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.

Authors:  A Parsons; A Daley; R Begh; P Aveyard
Journal:  BMJ       Date:  2010-01-21
View more
  3 in total

1.  SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis.

Authors:  Ruyang Zhang; Linjing Lai; Xuesi Dong; Jieyu He; Dongfang You; Chao Chen; Lijuan Lin; Ying Zhu; Hui Huang; Sipeng Shen; Liangmin Wei; Xin Chen; Yichen Guo; Liya Liu; Li Su; Andrea Shafer; Sebastian Moran; Thomas Fleischer; Maria Moksnes Bjaanaes; Anna Karlsson; Maria Planck; Johan Staaf; Åslaug Helland; Manel Esteller; Yongyue Wei; Feng Chen; David C Christiani
Journal:  Mol Oncol       Date:  2019-04-17       Impact factor: 6.603

2.  Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer.

Authors:  Anna Hung; Kyung Min Lee; Julie A Lynch; Yanhong Li; Pradeep Poonnen; Olga V Efimova; Bradley J Hintze; Trudy Buckingham; Candice Yong; Brian Seal; Michael J Kelley; Shelby D Reed
Journal:  BMC Cancer       Date:  2021-07-16       Impact factor: 4.430

3.  Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer.

Authors:  Te-Chun Shen; Wen-Shin Chang; Te-Chun Hsia; Chia-Wen Tsai; Da-Tian Bau; Hsin-Ting Li; Wei-Chun Chen
Journal:  Onco Targets Ther       Date:  2019-08-09       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.